Articles published by Atreca, Inc.
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
September 21, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
August 10, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
April 26, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
March 29, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
March 23, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
February 06, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
January 09, 2023
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca to Present at Upcoming Investor Conferences
November 07, 2022
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From Atreca, Inc.
Via GlobeNewswire
Tickers
BCEL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.